Zealand Pharma announces acceleration of U.S. commercial operations through the completion of the Valeritas acquisition; FDA acceptance of New Drug Application submission for the dasiglucagon HypoPal® rescue pen; pipeline progress including https://www.globenewswire.com/news-release/2020/08/13/2077930/0/en/Zealand-Pharma-announces-acceleration-of-U-S-commercial-operations-through-the-completion-of-the-Valeritas-acquisition-FDA-acceptance-of-New-Drug-Application-submission-for-the-das.html press release